Brock University Lung Nodule Malignancy Model
Estimates probability of malignancy in incidental pulmonary nodules detected on CT. Based on the Pan-Canadian Early Detection of Lung Cancer Study. Guides surveillance and biopsy decisions.
Score interpretation
Malignancy probability < 5 %
→ Routine follow-up per Fleischner/BTS guidelines; no urgent action required
Intermediate malignancy probability (5–10 %)
→ CT follow-up at 3–6 months to assess growth; discussion at MDT
Malignancy probability ≥ 10 % — the BTS threshold for further assessment (PET-CT)
→ Urgent MDT discussion; PET-CT; bronchoscopy or CT-guided biopsy; early surgical or oncological referral
Interpretation bands for the Brock Lung Model. Apply clinical judgement and local guidance.
References
Related
Curated clinical cross-links plus same-class fallbacks.
- Fong Clinical Risk Score for Colorectal Cancer Recurrence · Oncology
- CRASH Score for Chemotherapy Risk Assessment in Elderly Patients · Oncology
- Ann Arbor Staging System for Lymphoma · Oncology
- Rai Staging System for CLL · Oncology
- Follicular Lymphoma International Prognostic Index (FLIPI) · Oncology
- International Staging System for Multiple Myeloma (ISS) · Oncology
- Acute Asthma in Adults · BTS/SIGN British Guideline on Asthma 2019; NICE NG80
- Pulmonary Embolism Assessment · NICE NG158; ESC 2019 PE Guidelines
- Acute Exacerbation of COPD (AECOPD) · NICE NG115; GOLD 2024
- Spontaneous Pneumothorax (Adult) · BTS Pleural Disease 2023
- Atypical Pneumonia (Legionella / Mycoplasma / Chlamydophila) · BTS 2023; IDSA
- COPD Exacerbation Management · NICE NG115 / GOLD 2024
Decision support only — verify against a current formulary, NICE, or your local guideline before clinical use.
